Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
005725.KS Stock Summary
In the News
005725.KS Financial details
Company Rating
Neutral
Market Cap
224.79B
Income
48.3B
Revenue
3035.39B
Book val./share
22054.68
Cash/share
7817.09
Dividend
-
Dividend %
-
Employees
752
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
4.42
Forward P/E
-
PEG
0.02
P/S
0.07
P/B
0.13
P/C
0.39
P/FCF
-0.73
Quick Ratio
-
Current Ratio
1.13
Debt / Equity
1.58
LT Debt / Equity
0.38
-
-
EPS (TTM)
911.83
EPS next Y
-
EPS next Q
-
EPS this Y
2158.46%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-17.39%
Revenue last 5Y
5.77%
Revenue Q/Q
-2.41%
EPS Q/Q
-85.3%
-
-
-
-
SMA20
0.42%
SMA50
6.81%
SMA100
8.78%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
3%
ROC
0.04%
Gross Margin
24%
Oper. Margin
4%
Profit Margin
1%
Payout
-
Shs Outstand
75.36M
Shs Float
65.36M
-
-
-
-
Target Price
-
52W Range
2670.0-3190.0
52W High
-5.64%
52W Low
+12.73%
RSI
51.29
Rel Volume
0.18
Avg Volume
3.7K
Volume
681
Perf Week
-2.11%
Perf Month
2.03%
Perf Quarter
2.03%
Perf Half Y
1.69%
-
-
-
-
Beta
0.693
-
-
Volatility
5.89%, 22.25%
Prev Close
0%
Price
3010
Change
0.33%
005725.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 40.83K | 35.09K | 43.44K | 58.32K | 56.75K | |
Net income per share | 2.03K | 13.71 | 521.12 | 34.5 | 779.17 | |
Operating cash flow per share | 5.76K | 4.02K | 4.27K | -564.2 | 5.76K | |
Free cash flow per share | 1.49K | 1.71K | 1.82K | -6.1K | -769.92 | |
Cash per share | 5.92K | 9.14K | 9.73K | 7.78K | 7.74K | |
Book value per share | 18.36K | 18.74K | 19.85K | 21.9K | 21.84K | |
Tangible book value per share | 34.76K | 35.12K | 36.93K | 40K | 41.76K | |
Share holders equity per share | 18.36K | 18.74K | 19.85K | 21.9K | 21.84K | |
Interest debt per share | 23.15K | 26.6K | 26.91K | 34.46K | 35.58K | |
Market cap | 190.82B | 178.69B | 184.57B | 164.58B | 154.43B | |
Enterprise value | 1289.37B | 1335B | 1290.85B | 1583.37B | 1709.75B | |
P/E ratio | 1.68 | 232.27 | 6.4 | 92.62 | 3.71 | |
Price to sales ratio | 0.08 | 0.09 | 0.08 | 0.05 | 0.05 | |
POCF ratio | 0.59 | 0.79 | 0.78 | -5.66 | 0.5 | |
PFCF ratio | 2.29 | 1.86 | 1.83 | -0.52 | -3.75 | |
P/B Ratio | 0.19 | 0.17 | 0.17 | 0.15 | 0.13 | |
PTB ratio | 0.19 | 0.17 | 0.17 | 0.15 | 0.13 | |
EV to sales | 0.56 | 0.68 | 0.54 | 0.53 | 0.56 | |
Enterprise value over EBITDA | 3.07 | 5.43 | 4.75 | 7.35 | 3.96 | |
EV to operating cash flow | 3.99 | 5.92 | 5.47 | -54.48 | 5.56 | |
EV to free cash flow | 15.47 | 13.9 | 12.8 | -5.04 | -41.56 | |
Earnings yield | 0.6 | 0 | 0.16 | 0.01 | 0.27 | |
Free cash flow yield | 0.44 | 0.54 | 0.55 | -1.91 | -0.27 | |
Debt to equity | 1.24 | 1.4 | 1.34 | 1.55 | 1.58 | |
Debt to assets | 0.31 | 0.35 | 0.32 | 0.37 | 0.36 | |
Net debt to EBITDA | 2.62 | 4.71 | 4.07 | 6.59 | 3.6 | |
Current ratio | 1.76 | 1.58 | 1.43 | 1.04 | 1.2 | |
Interest coverage | 10.21 | 2.1 | 3.38 | 0.27 | 3.49 | |
Income quality | 2.84 | 293.28 | 8.02 | -16.36 | 7.39 | |
Dividend Yield | 0.05 | 0.06 | 0.06 | 0.07 | 0.08 | |
Payout ratio | 0.09 | 14.15 | 0.38 | 6.65 | 0.29 | |
Sales general and administrative to revenue | 0.05 | 0.06 | 0.05 | 0.04 | 0 | |
Research and developement to revenue | 0.04 | 0.05 | 0.04 | 0.03 | 0.03 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.74 | -0.57 | -0.57 | 9.81 | -1.13 | |
Capex to revenue | -0.1 | -0.07 | -0.06 | -0.09 | -0.11 | |
Capex to depreciation | -1.35 | -0.63 | -0.66 | -1.37 | -1.63 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 28.92K | 2.4K | 15.25K | 4.12K | 19.57K | |
ROIC | 0.05 | 0 | 0.02 | 0 | 0.04 | |
Return on tangible assets | 0.03 | 0 | 0.01 | 0 | 0.01 | |
Graham Net | -21.36K | -20.62K | -22.1K | -27.99K | -31.46K | |
Working capital | 519.64B | 494.94B | 492.59B | 69.29B | 294.66B | |
Tangible asset value | 1950.7B | 1970.21B | 2043.88B | 2060.58B | 2168.5B | |
Net current asset value | -876.14B | -853.91B | -810.01B | -957.96B | 1083.5B | |
Invested capital | 1.24 | 1.4 | 1.34 | 1.55 | 1.58 | |
Average receivables | 477.46B | 459.34B | 512.99B | 558.74B | 538.87B | |
Average payables | 136.75B | 113.17B | 121.7B | 161.94B | 142.89B | |
Average inventory | 370.83B | 389.52B | 452.79B | 609.08B | 679.79B | |
Days sales outstanding | 73.47 | 84.83 | 86.32 | 66.71 | 63.63 | |
Days payables outstanding | 29.3 | 23.86 | 28.35 | 25.8 | 17.69 | |
Days of inventory on hand | 91.96 | 91.92 | 103.06 | 99.76 | 109.7 | |
Receivables turnover | 4.97 | 4.3 | 4.23 | 5.47 | 5.74 | |
Payables turnover | 12.46 | 15.29 | 12.87 | 14.15 | 20.63 | |
Inventory turnover | 3.97 | 3.97 | 3.54 | 3.66 | 3.33 | |
ROE | 0.11 | 0 | 0.03 | 0 | 0.04 | |
Capex per share | -4.28K | -2.31K | -2.44K | -5.54K | -6.53K |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 15.85K | 12.64K | 13.61K | 13.6K | 14.33K | |
Net income per share | -190.43 | -82.6 | 342.6 | 510.2 | 81 | |
Operating cash flow per share | -78.15 | -1.04K | -46.3 | 2.83K | 3.93K | |
Free cash flow per share | -1.58K | -2.83K | -1.39K | 1.62K | 2.03K | |
Cash per share | 7.91K | 6.25K | 6.09K | 7.29K | 7.82K | |
Book value per share | 22.26K | 19.72K | 19.98K | 20.49K | 22.05K | |
Tangible book value per share | 40.65K | 36.41K | 36.92K | 38.05K | 42.18K | |
Share holders equity per share | 22.26K | 19.72K | 19.98K | 20.49K | 22.05K | |
Interest debt per share | 34.64K | 33.32K | 34.94K | 34.53K | 35.14K | |
Market cap | 161.96B | 176.86B | 178.29B | 168.58B | 152.91B | |
Enterprise value | 1580.76B | 1793.01B | 1890.35B | 1783.6B | 1708.22B | |
P/E ratio | -4.19 | -9.37 | 2.28 | 1.45 | 8.92 | |
Price to sales ratio | 0.2 | 0.24 | 0.23 | 0.22 | 0.2 | |
POCF ratio | -40.88 | -2.96 | -67.39 | 1.04 | 0.73 | |
PFCF ratio | -2.03 | -1.09 | -2.25 | 1.83 | 1.42 | |
P/B Ratio | 0.14 | 0.16 | 0.16 | 0.14 | 0.13 | |
PTB ratio | 0.14 | 0.16 | 0.16 | 0.14 | 0.13 | |
EV to sales | 1.97 | 2.48 | 2.43 | 2.3 | 2.25 | |
Enterprise value over EBITDA | 46.22 | 11.17 | 9.65 | 7.92 | 13.37 | |
EV to operating cash flow | -399.02 | -30.06 | -714.51 | 11.03 | 8.21 | |
EV to free cash flow | -19.78 | -11.1 | -23.83 | 19.32 | 15.91 | |
Earnings yield | -0.06 | -0.03 | 0.11 | 0.17 | 0.03 | |
Free cash flow yield | -0.49 | -0.91 | -0.44 | 0.55 | 0.7 | |
Debt to equity | 1.55 | 1.69 | 1.74 | 1.67 | 1.58 | |
Debt to assets | 0.37 | 0.39 | 0.4 | 0.38 | 0.36 | |
Net debt to EBITDA | 41.49 | 10.07 | 8.74 | 7.17 | 12.17 | |
Current ratio | 1.04 | 1.15 | 1.17 | 1.13 | 1.2 | |
Interest coverage | -1.61 | 8.14 | 3.33 | 5.36 | 3.45 | |
Income quality | 0.41 | 12.64 | -0.07 | 2.72 | 48.56 | |
Dividend Yield | 0 | 0 | 0.07 | 0 | 0 | |
Payout ratio | 0 | 0 | 0.61 | 0 | 0 | |
Sales general and administrative to revenue | 0.04 | 0.19 | 0.19 | 0.19 | 0 | |
Research and developement to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | 19.17 | 1.71 | 28.98 | -0.43 | -0.48 | |
Capex to revenue | -0.09 | -0.14 | -0.1 | -0.09 | -0.13 | |
Capex to depreciation | -1.48 | -2 | -1.45 | -1.3 | -1.77 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 9.77K | 6.05K | 12.41K | 15.34K | 6.34K | |
ROIC | 0 | 0 | 0.01 | 0.02 | 0.01 | |
Return on tangible assets | 0 | 0 | 0 | 0.01 | 0 | |
Graham Net | -28.44K | -27.48K | -28.17K | -27.76K | -31.77K | |
Working capital | 69.29B | 223.15B | 251.39B | 211.62B | 294.66B | |
Tangible asset value | 2060.58B | 2080.76B | 2109.74B | 2174.28B | 2168.5B | |
Net current asset value | -957.96B | 1065.98B | 1088.69B | 1072.58B | 1083.5B | |
Invested capital | 1.55 | 1.69 | 1.74 | 1.67 | 1.58 | |
Average receivables | 632.96B | 591.28B | 665.95B | 698.55B | 613.74B | |
Average payables | 190.1B | 166.09B | 157.62B | 154.73B | 129.42B | |
Average inventory | 718.77B | 682.47B | 681.61B | 673.48B | 671.11B | |
Days sales outstanding | 61.51 | 78.96 | 80.79 | 80.93 | 62.75 | |
Days payables outstanding | 24.41 | 24.93 | 24.7 | 24.42 | 18.49 | |
Days of inventory on hand | 94.39 | 109.3 | 105.35 | 108.56 | 114.67 | |
Receivables turnover | 1.46 | 1.14 | 1.11 | 1.11 | 1.43 | |
Payables turnover | 3.69 | 3.61 | 3.64 | 3.69 | 4.87 | |
Inventory turnover | 0.95 | 0.82 | 0.85 | 0.83 | 0.78 | |
ROE | -0.01 | 0 | 0.02 | 0.02 | 0 | |
Capex per share | -1.5K | -1.78K | -1.34K | -1.21K | -1.9K |
005725.KS Frequently Asked Questions
What is Nexen Corporation stock symbol ?
Nexen Corporation is a KR stock and trading under the symbol 005725.KS
What is Nexen Corporation stock quote today ?
Nexen Corporation stock price is $3010 today.
Is Nexen Corporation stock public?
Yes, Nexen Corporation is a publicly traded company.